University Hospitals Research & Education Institute

What an evening filled with inspiring stories from our incredible physicians on their journeys to promotion, and the joy of catching up with colleagues. Proud to celebrate excellence and share in the collective pride of our 2024 senior promoted faculty.

A $15 million gift from Iris S. and the late Bert L. Wolstein will advance the University Hospitals mission – To Heal. To Teach. To Discover – and give rise to the Iris S. and Bert L. Wolstein Center, a state-of-the-art education and conference center at UH Cleveland Medical Center. Mrs. Wolstein’s visionary lead gift launches a campaign to fully philanthropically fund the new center, estimated to cost $30 million. UH Cleveland Medical Center is one of the only major academic medical centers in the country without an education and conference center, but boasts one of the nation’s largest residency programs with nearly 1,200 residents and fellows. The new Iris S. and Bert L. Wolstein Center will transform UH’s capacity to convene and train healthcare professionals, an increasingly important priority as the country navigates a critical shortage in medical staff. The 30,000-square-foot facility will be equipped with state-of-the-art audiovisual and remote learning technology and provide ample and flexible space to host national and international conferences; visiting lecturers, professors and speakers; Continuing Medical Education conferences; and more. Dedicated simulation and training labs, breakout space, a cafe and a publicly accessible art gallery will round out the building. “The Iris S. and Bert L. Wolstein Center represents a deliberate investment in our caregivers,” said Daniel I. Simon, MD, President, Academic & External Affairs and UH Chief Scientific Officer, Ernie and Patti Novak Distinguished Chair in Health Care Leadership. “A mission-critical home for learning, it will allow us to deliver on our promise to teach and to discover in new, dynamic ways and in a stunning facility.” For more information, visit: https://lnkd.in/gwXsaJaK #innovation #healthcare #teaching #discovery

At University Hospitals neurosurgery now has the added advantage of a cranial robotic system. Michael Staudt, MD is now performing sEEG procedures for epilepsy with precision and speed, reducing surgery time. Read how the ROSA ONE is enhancing patient outcomes: https://lnkd.in/e8JFU7aQ

Discover the science behind the groundbreaking advancements in magnetic resonance fingerprinting imaging. Tune into the latest Science@UH podcast for expert insights from Chaitra Badve, MD and Dan Ma, PhD as they delve into this cutting-edge innovation in radiology: https://lnkd.in/eiyRJEBy

The largest study of its kind has revealed that routine lab tests aren't reliable for diagnosing Long COVID. With nearly 18 million U.S. adults affected, this research emphasizes the importance of focusing on symptoms rather than normal lab results. Grace McComsey, MD, underscores the need for clinical assessment until reliable biomarkers are discovered. Read more about this critical finding: https://lnkd.in/gNJrF4AF

Congratulations to Rod P. Rezaee, MD, this year’s Young Physicians Section (YPS) Model Mentor awardee! As Director of Head and Neck Surgical Oncology at University Hospitals and Professor at Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Dr. Rezaee is a leader in both patient care and medical education. His dedication to mentoring has shaped the careers of many young surgeons, and his contributions to national committees continue to advance the field of head and neck cancer treatment. We’re proud to recognize his outstanding impact! https://lnkd.in/gjSbRMXD

Exciting insights from the SELECT2 study reveal long-term benefits of stroke treatments beyond the initial 90 days. Discover how patient outcomes and quality of life continue to improve even after a year. Listen now to learn more! 

A new study co-authored by Varun Sundaram, MD, PhD, University Hospitals demonstrates the HFpEF-ABA Score's effectiveness in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF). This tool could revolutionize HFpEF diagnosis and care: https://lnkd.in/g5XNcybD

Congratulations to Our Early Career Abstract Award Winners! We are thrilled to celebrate the achievements of the talented professionals recognized for their groundbreaking research at the ADA Scientific Sessions. 🔗 See the full list of award winners: https://bit.ly/3VNmyY4 🌐 Let's celebrate these achievements and continue pushing the boundaries of diabetes research and care! Julia E. Blanchette, PhD, RN, BC-ADM, CDCES for “Insights on Inclusion—Tailoring a Health Insurance Toolkit to Diverse Emerging Adults with Type 1 Diabetes.” Faidat A. Ishola, MD for “GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes.” Armando Vergara-Martel, MS, BS for “Proteomic Analysis of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA)—Results and Integrated Predictors of Response.” Jithin Sam Varghese, PhD, MTech for “Racial Ethnic Disparities in Prescription of GLP1 Receptor Agonists for People at High Risk for Diabetes on Atypical Antipsychotics.” Shylaja Srinivasan, MD for “Obesity Is Associated with Increased Clearance and Reduced Drug Exposure to Metformin in Youth with Type 2 Diabetes.” Christine March, MD, MS for “ADA Diabetes Medical Management Plan Implementation—Barriers and Opportunities.” Yun Shen, MD for “Effectiveness of Continuous Glucose Monitoring on Short-Term In-hospital Mortality among Frail Critically Ill Patients with COVID-19.” Mark Pataky, PhD for “Posttranslational Modifications in Skeletal Muscle Direct Divergent Metabolic Responses to Different Exercise Training Modes.” Ward Fickweiler, MD, PhD for “Delaying Progression of Diabetic Retinopathy Worsens the Risk for Age-Related Macular Degeneration.” Kanhaiya Singh, PhD for “Lineage Tracing of Vasculogenic Fibroblasts In Vivo and Their Significance in the Rescue of Diabetic Ischemic Tissue.” Hamza Alshannaq, MD, MPH for “Cost-Effectiveness of Real-Time CGM vs. Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Intensive Insulin Therapy in Australia.” Mehmet H. Kural, PhD for “Preliminary Results of Islet Survival in a Novel Biovascular Pancreas Implanted in Primates.” Hannah R. Foster for “Signaling Mechanisms Underlying Islet Compensation in a Novel Mouse Model of ß-Cell Replication Deficiency.” Adam David Seal, PhD for “ADA Presidents' Select Abstract: Oral Bisphenol A Administration Decreased Peripheral Insulin Sensitivity in Healthy Adults.” Emily A. Rosenberg, MD for “Insulin Sensitivity and Insulin Secretion Differentially Affect Birthweight and Postpartum Glucose.” Yilin Yoshida, PhD, MPH for “Sex Differences in Metabolomics and Risk of Coronary Heart Disease in Type 2 Diabetes.”

N. Scott Howard MD, and Benjamin Young, MD, University Hospitals recently implanted the first ever patient-specific 3D printed T-tube into a human patient. Read how this custom device was granted FDA compassionate use to improve outcomes for one patient: https://lnkd.in/etGT-tjp